Peter Reichardt
- Gastroenterology top 0.02%
- Gastrointestinal Tumor Research and Treatment 146
- Pulmonary and Respiratory Medicine top 0.05%
- Sarcoma Diagnosis and Treatment 151
- Gastric Cancer Management and Outcomes 124
- Metastasis and carcinoma case studies 25
- Oncology top 0.5%
- Vascular Tumors and Angiosarcomas 42
- Colorectal Cancer Treatments and Studies 29
- Rheumatology top 0.2%
- Surgery top 0.5%
- Gastrointestinal disorders and treatments 38
-
- Cardiac tumors and thrombi 27
- Co-authors
- Jean‐Yves BlayPaolo G. CasaliJaap VerweijPeter HohenbergerDaniel PinkM. van GlabbekePancras C.W. HogendoornIan Judson
- Journals
- Journal of Clinical Oncology (87 papers)Annals of Oncology (37 papers)European Journal of Cancer (29 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Peter Reichardt
339 papers receiving 15.2k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Gastroenterology 5.7k
- Pulmonary and Respiratory Medicine 9.7k
- Oncology 4.2k
- Rheumatology 2.1k
- Surgery 4.2k
Countries citing papers authored by Peter Reichardt
This map shows the geographic impact of Peter Reichardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Reichardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Reichardt more than expected).
Fields of papers citing papers by Peter Reichardt
This network shows the impact of papers produced by Peter Reichardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Reichardt. The network helps show where Peter Reichardt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Reichardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 13 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 7 | |
| 11 | 2022 | 26 | |
| 12 | 2021 | 33 | |
| 13 | 2018 | 18 | |
| 14 | 2015 | 149 | |
| 15 | 2015 | 85 | |
| 16 | 2013 | 36 | |
| 17 | Time course of adverse events in the phase III GRID study of regorafenib in patients with metastatic gastrointestinal stromal tumors (GIST) | 2013 | 1 |
| 18 | Lack of trial participation and lack of centralization for young adults with osteosarcoma: Experience from the European and American Osteosarcoma Study, EURAMOS-1 | 2012 | 1 |
| 19 | 2009 | 24 | |
| 20 | 1995 | 2 |
About Peter Reichardt
Peter Reichardt is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Oncology, having authored 354 papers that have together received 15.6k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (151 papers), Gastrointestinal Tumor Research and Treatment (146 papers), Gastric Cancer Management and Outcomes (124 papers), Vascular Tumors and Angiosarcomas (42 papers), Gastrointestinal disorders and treatments (38 papers), Colorectal Cancer Treatments and Studies (29 papers), Cardiac tumors and thrombi (27 papers) and Metastasis and carcinoma case studies (25 papers). The work is most often cited by research in Gastroenterology (5.7k citations), Pulmonary and Respiratory Medicine (9.7k citations) and Oncology (4.2k citations). Peter Reichardt has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Jean‐Yves Blay, Paolo G. Casali, Jaap Verweij, Peter Hohenberger, Daniel Pink, M. van Glabbeke, Pancras C.W. Hogendoorn, Ian Judson, Rolf D. Issels and John Zalcberg. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Future Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.